Perphenazine
Product Images NDC 52959-940

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Perphenazine (NDC 52959-940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is An Image Of The Structural Formula Of Perphenazine. (Perphenazine 1)

FDA Label Image

Principal Display Panel For Perphenazine Tablets 8 mg 100 Tablets (Perphenazine 4)

Principal Display Panel For Perphenazine Tablets 8 mg 100 Tablets (Perphenazine 4)
This is a description of a Perphenazine 8mg tablet, a medication for treating mental disorders, including schizophrenia. The tablet is round, grey, and coated with sugar, with the identification code "0603-5092-21". The directions and usual dosage information are available in an insert accompanying the medication. The manufacturer is Qualitest, and the lot number of the specific package is PPZOTQT, with an expiry date of 05/10. It is intended to be taken as directed by a doctor or a licensed healthcare provider.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.